Research location
Smolensk
Russia
Advertisement
Research activity in Smolensk
RussiaCureCurrent currently publishes aggregate city-level research activity for this location: 254 trials and 267 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Smolensk
254 linked trials · page 1 of 6Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry StudyNCT06521229 · 2024-06-27 · 1 site observation
RECRUITING
Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)NCT06472310 · 2024-06-06 · 1 site observation
RECRUITING
A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung CancerNCT05654454 · 2023-05-31 · 2 site observations
RECRUITING
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsNCT04373564 · 2021-03-24 · 1 site observation
RECRUITING
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With SchizophreniaNCT03817502 · 2019-06-06 · 1 site observation
RECRUITING
A Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of RPH-035 and Ocrevus® in Patients With Relapsing-remitting or Secondary Progressive Multiple Sclerosis With ExacerbationsNCT07597668 · 2025-04-16 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast CancerNCT07386938 · 2024-08-09 · 1 site observation
ACTIVE_NOT_RECRUITING
Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in RussiaNCT06338839 · 2023-12-28 · 1 site observation
TERMINATED
HER2-low Unresectable and/or Metastatic Breast Cancer in RussiaNCT05913440 · 2023-05-30 · 1 site observation
COMPLETED
Comparison of Complarate® (Tocilizumab Biosimilar) and Actemra® in Patients With Rheumatoid ArthritisNCT06475508 · 2023-02-13 · 1 site observation
COMPLETED
The Study of High-protein Nutritional Support Impact on Postoperative Outcomes in Patients With Primary Lung CancerNCT05710354 · 2022-06-01 · 1 site observation
COMPLETED
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple SclerosisNCT05269004 · 2022-05-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple SclerosisNCT05201638 · 2022-01-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are OverweightNCT04657003 · 2021-03-29 · 1 site observation
COMPLETED
Heart Failure Patients RegistryNCT04709263 · 2020-12-21 · 1 site observation
COMPLETED
A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With DepressionNCT04521478 · 2020-11-20 · 1 site observation
COMPLETED
A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive AdultsNCT04493216 · 2020-11-18 · 1 site observation
TERMINATED
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)NCT04411641 · 2020-09-24 · 1 site observation
COMPLETED
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of SchizophreniaNCT04531982 · 2020-08-05 · 1 site observation
COMPLETED
MSB11456 in Participants With Moderately to Severely Active Rheumatoid ArthritisNCT04512001 · 2020-08-03 · 1 site observation
COMPLETED
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)NCT04410978 · 2020-06-30 · 1 site observation
COMPLETED
Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From DepressionNCT04448431 · 2020-06-18 · 1 site observation
COMPLETED
Study of Evobrutinib in Participants With RMS (evolutionRMS 1)NCT04338022 · 2020-06-12 · 1 site observation
TERMINATED
Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)NCT04333147 · 2020-05-12 · 1 site observation
TERMINATED
A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid ArthritisNCT04230213 · 2020-01-13 · 2 site observations
COMPLETED
A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.NCT04115319 · 2019-11-21 · 1 site observation
COMPLETED
An Extension Study of Ublituximab in Participants With Relapsing Multiple SclerosisNCT04130997 · 2019-11-18 · 1 site observation
ACTIVE_NOT_RECRUITING
House Dust Mite Allergy Trial In ChildrenNCT04145219 · 2019-10-12 · 1 site observation
COMPLETED
A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMSNCT04121221 · 2019-09-19 · 1 site observation
COMPLETED
Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)NCT03961204 · 2019-08-15 · 1 site observation
COMPLETED
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 DiabetesNCT03740919 · 2019-04-07 · 1 site observation
COMPLETED
Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic FailureNCT03750552 · 2019-01-24 · 1 site observation
COMPLETED
The Use of TrIple Fixed-dose Combination in the Treatment of Arterial HypertensionNCT03722524 · 2018-10-01 · 1 site observation
COMPLETED
A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® InhalerNCT03663569 · 2018-08-15 · 2 site observations
COMPLETED
An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial AsthmaNCT04607629 · 2018-06-20 · 1 site observation
COMPLETED
A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its SafetyNCT03541174 · 2018-06-18 · 1 site observation
COMPLETED
Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.NCT03703869 · 2018-03-06 · 2 site observations
COMPLETED
Oncoxin® and Quality of Life in Cancer PatientsNCT03550482 · 2017-11-01 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected AdultsNCT03299049 · 2017-10-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase IIb Study of Evobrutinib in Subjects With Rheumatoid ArthritisNCT03233230 · 2017-09-18 · 1 site observation
COMPLETED
Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple SclerosisNCT03232073 · 2017-07-05 · 1 site observation
COMPLETED
Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseNCT03162055 · 2017-05-25 · 1 site observation
COMPLETED
Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)NCT03061812 · 2017-04-11 · 1 site observation
COMPLETED
Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma TreatmentNCT03052517 · 2017-03-21 · 1 site observation
TERMINATED
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)NCT03033511 · 2017-02-07 · 1 site observation
TERMINATED
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With SchizophreniaNCT02970929 · 2017-01-31 · 1 site observation
COMPLETED
Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With AsthmaNCT03012061 · 2017-01-25 · 1 site observation
COMPLETED
Extension Study of Pimavanserin for the Adjunctive Treatment of SchizophreniaNCT03121586 · 2017-01-01 · 1 site observation
TERMINATED
Phase 4 Study of Dolutegravir (DTG) in Russian FederationNCT03314064 · 2016-12-08 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With SchizophreniaNCT02969382 · 2016-12-05 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.